【结 构 式】 |
【药物名称】SNC-80 【化学名称】(+)-4-[(alphaR)-alpha-[(2S,5R)-4-Allyl-2,5-dimethylpiperazin-1-yl]-3-methoxybenzyl]-N,N-diethylbenzamide 【CA登记号】156727-74-1 【 分 子 式 】C28H39N3O2 【 分 子 量 】449.64193 |
【开发单位】GlaxoSmithKline (Originator), National Institutes of Health (Originator) 【药理作用】ANALGESIC AND ANESTHETIC DRUGS, Analgesic Drugs, Antiparkinsonian Drugs, Extrapyramidal Disorders, Treatment of, NEUROLOGIC DRUGS, Opioid Analgesics, delta-Opioid Agonists |
合成路线1
Friedel-Crafts acylation of toluene (II) with 3-methoxybenzoyl chloride (I) gave benzophenone (III). Subsequent methyl group oxidation using KMnO4 afforded carboxylic acid (IV), which was further converted to amide (V) by activation with SOCl2, followed by treatment with diethylamine. Reduction of the keto group of (V) by means of NaBH4 yielded alcohol (VI). The required benzhydryl chloride (VII) was then prepared by treatment of alcohol (VI) with concentrated HCl.
【1】 Evans, S.M.; Lenz, G.R.; Probes of receptor mediated phenomena 19. Synthesis of (+)-4-[(alphaR)-alpha((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N-diethylbenzamide (SNC 80): A highly selective, nonpeptide delta opioid receptor agonist. Chemtracts - Org Chem 1994, 7, 6, 395. |
【2】 Calderon, S.N.; et al.; Probes for narcotic receptor mediated phenomena: 23. Synthesis, opioid receptor binding, and bioassay of the highly selective delta agonist (+)-4-[(alphaR)-alpha-((2S,5R)-4-allyl-2, 5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N, N-diethylbenzamide (SNC 80). J Med Chem 1997, 40, 5, 695. |
【3】 Calderon, S.N.; et al.; Probes for narcotic receptor mediated phenomena. 19. Synthesis of (+)-4-[(alphaR)-alpha-((2S,5R)-4-allyl-2, 5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N, N-diethylbenzamide (SNC 80): A highly selective, nonpeptide delta opioid receptor agonist. J Med Chem 1994, 14, 37, 2125. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 16760 | 3-methoxybenzoyl chloride | 1711-05-3 | C8H7ClO2 | 详情 | 详情 |
(II) | 12890 | Toluene | 108-88-3 | C7H8 | 详情 | 详情 |
(III) | 56245 | (3-methoxyphenyl)(4-methylphenyl)methanone | C15H14O2 | 详情 | 详情 | |
(IV) | 56246 | 4-(3-methoxybenzoyl)benzoic acid | C15H12O4 | 详情 | 详情 | |
(V) | 56247 | N,N-diethyl-4-(3-methoxybenzoyl)benzamide | C19H21NO3 | 详情 | 详情 | |
(VI) | 56248 | N,N-diethyl-4-[hydroxy(3-methoxyphenyl)methyl]benzamide | C19H23NO3 | 详情 | 详情 | |
(VII) | 56249 | 4-[chloro(3-methoxyphenyl)methyl]-N,N-diethylbenzamide | C19H22ClNO2 | 详情 | 详情 |
合成路线2
The alkylation of trans-2,5-dimethylpiperazine (VIII) with allyl bromide gave rise to a racemic mixture of N-allylpiperazines, which was resolved using (-)-camphoric acid. The desired (2R,5S)-piperazine (IX) was then alkylated with benzhydryl chloride (VII) producing a mixture of the title compound and its benzhydryl epimer (X), which were separated by flash column chromatography.
【1】 Evans, S.M.; Lenz, G.R.; Probes of receptor mediated phenomena 19. Synthesis of (+)-4-[(alphaR)-alpha((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N-diethylbenzamide (SNC 80): A highly selective, nonpeptide delta opioid receptor agonist. Chemtracts - Org Chem 1994, 7, 6, 395. |
【2】 Calderon, S.N.; et al.; Probes for narcotic receptor mediated phenomena: 23. Synthesis, opioid receptor binding, and bioassay of the highly selective delta agonist (+)-4-[(alphaR)-alpha-((2S,5R)-4-allyl-2, 5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N, N-diethylbenzamide (SNC 80). J Med Chem 1997, 40, 5, 695. |
【3】 Calderon, S.N.; et al.; Probes for narcotic receptor mediated phenomena. 19. Synthesis of (+)-4-[(alphaR)-alpha-((2S,5R)-4-allyl-2, 5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N, N-diethylbenzamide (SNC 80): A highly selective, nonpeptide delta opioid receptor agonist. J Med Chem 1994, 14, 37, 2125. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(VII) | 56249 | 4-[chloro(3-methoxyphenyl)methyl]-N,N-diethylbenzamide | C19H22ClNO2 | 详情 | 详情 | |
(VIII) | 20687 | (2R,5S)-2,5-dimethylpiperazine | C6H14N2 | 详情 | 详情 | |
(IX) | 20690 | (2R,5S)-1-allyl-2,5-dimethylpiperazine | C9H18N2 | 详情 | 详情 | |
(X) | 56250 | 4-[(S)-[(2S,5R)-4-allyl-2,5-dimethylpiperazinyl](3-methoxyphenyl)methyl]-N,N-diethylbenzamide | C28H39N3O2 | 详情 | 详情 |
合成路线3
In a different synthetic strategy, 4-formylbenzoic acid (XI) was first coupled to diethylamine by means of EDC to yield N,N-diethyl 4-formylbenzamide (XII). The intermediate iminium salt produced by condensation between aldehyde (XII) and the chiral piperazine (IX) was then isolated as the benzotriazole adduct (XIII). Displacement of the benzotriazolyl group by the Grignard reagent (XIV) produced the title diastereoisomer as the major product, which was further enriched by recrystallization from acetonitrile/water.
【1】 Report from ASCO 2002 - Docetaxel improves survival in node-positive early-stage breast cancer patients. Oncology (USA) 2002, 16, 8, 1054. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(IX) | 20690 | (2R,5S)-1-allyl-2,5-dimethylpiperazine | C9H18N2 | 详情 | 详情 | |
(XI) | 18922 | 4-formylbenzoic acid | 619-66-9 | C8H6O3 | 详情 | 详情 |
(XII) | 45932 | N,N-diethyl-4-formylbenzamide | C12H15NO2 | 详情 | 详情 | |
(XIII) | 56251 | 4-[[(2S,5R)-4-allyl-2,5-dimethylpiperazinyl](1H-1,2,3-benzotriazol-1-yl)methyl]-N,N-diethylbenzamide | C27H36N6O | 详情 | 详情 | |
(XIV) | 35984 | bromo(3-methoxyphenyl)magnesium | 36282-40-3 | C7H7BrMgO | 详情 | 详情 |